How does deprescribing nephrotoxic OTCs (NSAIDs) in CKD change eGFR slope, what practice-change studies show, and how does this compare with pharmacist alerts alone?

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.

How does deprescribing nephrotoxic OTCs (NSAIDs) in CKD change eGFR slope, what practice-change studies show, and how does this compare with pharmacist alerts alone?

Deprescribing nephrotoxic over-the-counter (OTC) medications like NSAIDs in Chronic Kidney Disease (CKD) can significantly slow the rate of kidney function decline, thereby improving the eGFR slope. This proactive approach, involving patient education and direct intervention, is more effective at changing long-term patient behavior and preserving kidney function than relying on pharmacist alerts alone, which act as a safety net but are less effective at preventing initial, patient-driven use.

The Kidney Under Siege: How NSAIDs Cause Harm কিডনি

To understand the benefit of stopping nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen, it’s crucial to understand how they harm already vulnerable kidneys. Healthy kidney function relies on a steady, robust flow of blood. The kidneys have a natural protective mechanism, mediated by molecules called prostaglandins, which help to keep the small arteries supplying the filtering units (the glomeruli) open and dilated, ensuring adequate blood flow. This is especially important in CKD, where the kidneys are already working under stress. NSAIDs work by blocking enzymes called COX-1 and COX-2, which are responsible for producing these protective prostaglandins. When a person with CKD takes an NSAID, the production of these prostaglandins is inhibited. As a result, the arteries leading to the glomeruli constrict, leading to a sharp reduction in renal blood flow. This has two major negative consequences. Acutely, it can cause a temporary but significant drop in the estimated Glomerular Filtration Rate (eGFR), and in severe cases, can lead to acute kidney injury (AKI) on top of the chronic disease. Chronically, this repeated or sustained reduction in blood flow starves the kidney tissue of oxygen, causing progressive damage and scarring (fibrosis). This ongoing damage accelerates the natural downward trajectory of kidney function in CKD. Therefore, deprescribing NSAIDs is a direct intervention to remove this harmful hemodynamic stress, preserve blood flow to the remaining functional kidney tissue, and thereby flatten the eGFR slope, meaning the rate of kidney function decline is slowed

Evidence from the Frontlines: What Practice-Change Studies Reveal 🏥

The positive impact of actively deprescribing NSAIDs is well-documented in a variety of practice-change studies. These are real-world initiatives where healthcare systems implement a specific strategy to reduce the use of a harmful medication and then measure the outcomes. For instance, several studies have focused on pharmacist-led “academic detailing” or direct patient counseling. In these models, a clinical pharmacist meets with CKD patients who are identified as regular NSAID users. During these sessions, the pharmacist explains in clear, simple terms how NSAIDs harm their kidneys, explores the reasons for their NSAID use (e.g., chronic pain), and recommends safer alternatives for pain management, such as acetaminophen or non-pharmacological therapies. The results from these studies are compelling. They consistently show a significant reduction, often over 50%, in NSAID use among the targeted patient group. More importantly, when researchers have tracked the clinical outcomes, they’ve often found a stabilization of the eGFR slope in the months following the intervention. Patients who successfully stopped taking NSAIDs showed a much slower rate of kidney function decline compared to those who continued to use them. These studies demonstrate that a proactive, educational approach doesn’t just reduce pill consumption; it translates into a tangible, kidney-protective clinical benefit that can delay the progression to kidney failure and the need for dialysis.

A Proactive Strategy vs. A Reactive Warning: A Comparative Analysis 🤔

When comparing a comprehensive deprescribing program with the use of pharmacist alerts alone, we are comparing a proactive, patient-centered strategy with a reactive, system-level safety net. Pharmacist alerts are typically automated warnings generated by a pharmacy’s computer system when a prescription for an NSAID is being filled for a patient with a diagnosis of CKD in their record. These alerts are crucial for catching potentially inappropriate prescriptions from doctors and serve as an important last line of defense. However, their major limitation is that they do not address the widespread problem of over-the-counter (OTC) use. A patient can easily purchase ibuprofen or naproxen without a prescription, and the pharmacy alert system would have no knowledge of it. This is where proactive deprescribing initiatives are fundamentally more effective. These programs focus on patient education and empowerment. By sitting down with a patient and explaining the “why” behind the recommendation, they address the root of the problem: a lack of awareness of the danger. This approach changes the patient’s long-term health behavior, making them an active participant in protecting their own kidneys. It prevents them from both asking for prescriptions and from purchasing NSAIDs over the counter. While pharmacist alerts are an essential safety feature for prescribed medications, they are a passive and incomplete solution. A comprehensive deprescribing program that includes direct patient education and counseling is a far more robust and effective strategy for reducing total NSAID exposure, changing the eGFR trajectory, and ultimately preserving long-term kidney health.

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. Learn more